MDwerks Enters into Claims Purchase Agreement with California Based Pharmaceutical Company

  
    
  
  
    
      MDwerks, Inc. (OTCBB: MDWK), a provider of innovative web-based, 
      electronic claims management and funding solutions for healthcare 
      professionals, announced today its wholly owned subsidiary, Xeni 
      Financial Services, Corp. has entered into a three-year Claims Purchase 
      Agreement with a large California based processor of medical compound 
      prescriptions. Under the Agreement, Xeni Financial Services, Corp. will 
      purchase certain qualified workers compensation prescription claims 
      submitted by the processor to various medical and California State and 
      Local payers at a discounted value, for expected collection of the full 
      claim value by Xeni Financial Services, Corp.
    
    
      In connection with the Agreement, MDwerks, Inc., through its 
      subsidiaries, will use its electronic claims management and funding 
      solutions to analyze, estimate the value, purchase and monitor 
      collections for these claims. The customer has agreed to offer a monthly 
      target of $1.5 million in expected collections for purchase by Xeni 
      Financial Services, Corp.
    
    
      In consideration of the assistance of Medical Solutions Management, Inc. 
      in procuring the Agreement for MDwerks, Inc. and for terminating an 
      existing claims purchasing agreement with the customer, MDwerks, Inc. 
      has agreed in principal to issue two million shares of common stock to 
      Medical Solutions Management, Inc. The issuance of such shares is 
      subject to the entry into a definitive agreement by and between MDwerks, 
      Inc. and Medical Solutions Management, Inc. and it is also subject to 
      the closing of an additional round of financing of MDwerks, Inc.
    
    
      "This Claims Purchase Agreement is a breakthrough event for our Company 
      and is expected to produce significant new revenue while providing 
      enhanced cash flow for our customer’s business 
      growth. We are pleased to be offering the benefits of our technology and 
      financing services for this pharmaceutical client and expect to start 
      recognizing revenue from this agreement during the second quarter of 
      2008,” said Howard Katz, CEO, MDwerks, Inc.
    
    
      About MDwerks, Inc.
    
    
      MDwerks, Inc., (OTCBB: MDWK), based in Deerfield Beach, Florida, 
      provides healthcare professionals with automated electronic insurance 
      claims management solutions and advance funding of medical claims.
    
    
      MDwerksTM solutions comprise an innovative 
      web-based, HIPAA-compliant system of comprehensive administrative and 
      financial services designed for physician practices of all sizes and 
      specialties whether in a single or multi-location operation. Financial 
      lenders, healthcare payers and other related businesses also benefit 
      from MDwerks' solutions. For more information about the Company, please 
      visit www.mdwerks.com.
    
    
      Certain statements in this news release may contain forward-looking 
      information within the meaning of Rule 175 under the Securities Act of 
      1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are 
      subject to the safe harbor created by those rules. All statements, other 
      than statements of fact, included in this release, including, without 
      limitation, statements regarding potential future plans and objectives 
      of the companies, are forward-looking statements that involve risks and 
      uncertainties. There can be no assurance that such statements will prove 
      to be accurate and actual results and future events could differ 
      materially from those anticipated in such statements. Factors that could 
      cause actual results to differ materially from those in the 
      forward-looking statements include, among other things, the following: 
      general economic and business conditions; competition; unexpected 
      changes in technologies and technological advances; ability to 
      commercialize and manufacture products; results of experimental studies; 
      research and development activities; changes in, or failure to comply 
      with, governmental regulations; and the ability to obtain adequate 
      financing in the future. This information is qualified in its entirety 
      by cautionary statements and risk factors disclosure contained in 
      certain of MDwerks' Securities and Exchange Commission filings available 
      at http://www.sec.gov.